BIOLOGICS PRICE COMPETITION AND INNOVATION ACT

Bills and resolutions

FDA: make permanent the policy to speed up time for biosimilar products to get approved and made available to consumers (see S. 1140), S2432 [11AP] (see H.R. 2011), H2938 [1AP]

——— speed up approvals of lower-cost, generic, and ‘‘follow-on’’ insulin products (see S. 2103), S4807 [11JY] (see H.R. 5444), H10608 [17DE]

Texts of

S. 2103, Affordable Insulin Approvals Now Act, S4809 [11JY]